Biolidics launches IPO to raise S$6.1m
Add BT as a preferred source
Singapore
MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on the Catalist board on Dec 19.
The shares will be placed out to retail and institutional investors in Singapore, and represent 11.34 per cent of the company's enlarged share capital. Upon completion of the IPO, Biolidics' market capitalisation is expected to be S$67.9 million.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
MAS convenes bank CEOs over AI cyberthreats; boards told to own risks, not leave to IT teams
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
LTA circular to potential EV charger owners reveals hundreds of e-mail addresses under carbon copy feature
